Trash to treasure: A human beard derived photothermal drug delivery platform for depression therapy

Guoliang Zhang,Xiangfei Liu,Weichang Xie,Can Hong,Yingying Xu,Wei Zhang,Siyu Zhao,Hongbo Xin,Xiaolei Wang
DOI: https://doi.org/10.1016/j.apmt.2020.100891
IF: 8.663
2021-03-01
Applied Materials Today
Abstract:<p>Depression medication is still facing challenges, where the key issue is to explore a desirable delivery platform to assist drugs in penetrating blood-brain barrier (BBB). Herein, we prepared beard nanoscale particles (BNPs) from the beard of young Asian males, which were mainly composed by keratin and melanin. BNPs were able to load antidepressants (Fluoxetine) and exhibited therapeutic effect on depression. Moreover, <em>in vitro</em> and <em>in vivo</em> studies showed that BNPs held favorable photothermal conversion capability, prominent BBB permeability under near-infrared (NIR) irradiation and reliable biocompatibility. Deserved to be mentioned, BNPs also performed a pivotal role in redox equilibrium, which was thus capable of scavenging ROS induced by depression. Subsequently, behavioral and biochemical experiments also demonstrated significant depression-ameliorating effects <em>in vivo</em>. In summary, our data for the first time suggested that biological organism derived beard could serve as ideal low-cost nanovectors for depression therapy.</p>
materials science, multidisciplinary
What problem does this paper attempt to address?
The problem this paper attempts to address is the challenge of drug delivery in the treatment of depression. Specifically, the article points out that depression is a prevalent mental disorder affecting 340 million people worldwide, bringing high economic burdens and risks of relapse or disability. The current challenges in depression treatment include long onset times for medications, high costs, and difficulty in penetrating the blood-brain barrier (BBB). Therefore, improving drug efficacy, shortening onset times, and reducing treatment costs are urgent issues to be resolved. The core challenge of the research is how to overcome the unique obstacle of the blood-brain barrier to enhance drug delivery to the brain. This paper proposes an innovative approach, utilizing human hair to prepare nanoparticles (BNPs) to achieve effective drug delivery and improve depression symptoms.